l-carnitine tmao koeth 2013 nature medicine γ-Butyrobetaine Is a Proatherogenic Intermediate in Gut Microbial Metabolism of to l carnitine tmao nature medicine
l carnitine tmao nature medicine 2013 koeth Gut microbiota metabolism of l carnitine and cardiovascular risk Dietary allicin reduces transformation of Comparison of short term and long term effects of peroral L carnitine intake: clinical implications of elevated TMAO levels in cardiovascular complications Frontiers TMAO as a potential biomarker and therapeutic target for chronic kidney disease: A review The gutbrain axis and trimethylamine N oxide: an emergent biomarker in neurological diseases ScienceDirect
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8



